Malignant Peritoneal Neoplasm — Trials

Malignant Peritoneal Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

502 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 124
Recruiting: 53
Ph III recruiting: 7
Growth YoY: —
Industry share: 18%
Top sponsor: National Cancer Institute (NCI)
Termination share: 29.5%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (75)

clinicaltrialsPublishedShowing 51–57 of 57 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT05718726	Post Splenectomy Infections After Surgery for Peritoneal Malignancies (OPSI)(OPSI)	recruiting	—	300	Hampshire Hospitals NHS Foundation TrustOTHER	1	Nov 27, 2024	clinicaltrials
NCT06543069	Sintilimab, Bevacizumab, Pemetrexed, and Cisplatin for Unresectable MPeM	recruiting	Phase 2	28	Cancer Institute and Hospital, Chinese Academy of Medical SciencesOTHER	1